Fjarde Ap Fonden (The Fourth Swedish National Pensionfund) Jazz Pharmaceuticals PLC Transaction History
Fjarde Ap Fonden (The Fourth Swedish National Pensionfund)
- $8.86 Billion
- Q2 2024
A detailed history of Fjarde Ap Fonden (The Fourth Swedish National Pensionfund) transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Fjarde Ap Fonden (The Fourth Swedish National Pensionfund) holds 2,020 shares of JAZZ stock, worth $249,692. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,020Holding current value
$249,692% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding JAZZ
# of Institutions
502Shares Held
57.7MCall Options Held
155KPut Options Held
152K-
Vanguard Group Inc Valley Forge, PA6.32MShares$782 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.15MShares$760 Million0.02% of portfolio
-
Lsv Asset Management Chicago, IL2.48MShares$307 Million0.58% of portfolio
-
Capital World Investors Los Angeles, CA2.02MShares$250 Million0.04% of portfolio
-
State Street Corp Boston, MA2.02MShares$249 Million0.01% of portfolio
About Jazz Pharmaceuticals plc
- Ticker JAZZ
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,680,700
- Market Cap $7.75B
- Description
- Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...